Human Reproduction, Vol. 18, No. 11, 2368-2374,
November 2003
© 2003 European Society of Human Reproduction and Embryology
Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound
1 Department of Reproductive and Developmental Sciences, University of Edinburgh and 2 MRC Human Reproductive Sciences Unit, University of Edinburgh Chancellors’ Building, Edinburgh, UK
3 To whom correspondence should be addressed at: Department of Reproductive and Developmental Sciences, University of Edinburgh, Edinburgh, UK. e-mail: Louise.Bath{at}luht.scot.nhs.uk
BACKGROUND: Treatment of cancer during childhood may result in loss of primordial follicles from the ovary. METHODS: Ten cancer survivors and 11 controls with regular menstrual cycles, in addition to 10 cancer survivors and 10 controls taking the combined oral contraceptive pill (COCP) were recruited. Subjects were investigated on days 3–5 of a menstrual cycle, or week 3 of COCP administration before and 24 h after administration of 225 IU FSH. RESULTS: Serum FSH levels were elevated in cancer survivors with regular menstrual cycles (7.5 ± 1.4 versus 4.2 ± 0.3 IU/l; P = 0.02), while anti-Müllerian hormone (AMH) levels were lower (13.0 ± 3.0 versus 21.0 ± 3.4 pmol/l; P < 0.05). Other hormone levels were unchanged. Ovarian volume was smaller in cancer survivors than controls (3.0 ± 0.5 versus 5.0 ± 0.8 ml; P < 0.05), but antral follicle count (AFC) was similar. During COCP administration, inhibin B remained undetectable in six cancer survivors after FSH administration, whereas all controls showed a rise in inhibin B levels. The AFC was lower in cancer survivors than in controls (4.2 ± 0.8 versus 7.2 ± 0.8; P = 0.02). Ovarian volume was low in both groups, but did not differ between them. CONCLUSIONS: The study results demonstrate both hormonal and biophysical evidence of partial loss of the ovarian reserve in young cancer survivors. This was detected both in women with normal menstrual cycles and during COCP administration.
Key words: anti-Müllerian hormone/antral follicle count/chemotherapy/inhibin B/ovarian reserve
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. C. Reulen, M. P. Zeegers, W. H. B. Wallace, C. Frobisher, A. J. Taylor, E. R. Lancashire, D. L. Winter, M. M. Hawkins, and on behalf of the British Childhood Cancer Survivor Pregnancy Outcomes among Adult Survivors of Childhood Cancer in the British Childhood Cancer Survivor Study Cancer Epidemiol. Biomarkers Prev., August 1, 2009; 18(8): 2239 - 2247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lie Fong, J.S.E. Laven, F.G.A.J. Hakvoort-Cammel, I. Schipper, J.A. Visser, A.P.N. Themmen, F.H. de Jong, and M.M. van den Heuvel-Eibrink Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone Hum. Reprod., April 1, 2009; 24(4): 982 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Anderson, A. Weddell, H. A. Spoudeas, C. Douglas, S. M. Shalet, G. Levitt, and W. H. B. Wallace Do doctors discuss fertility issues before they treat young patients with cancer? Hum. Reprod., October 1, 2008; 23(10): 2246 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. W Kabithe and N. J Place Photoperiod-dependent modulation of anti-Mullerian hormone in female Siberian hamsters, Phodopus sungorus Reproduction, March 1, 2008; 135(3): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lie Fong, P.J. Lugtenburg, I. Schipper, A.P.N. Themmen, F.H. de Jong, P. Sonneveld, and J.S.E. Laven Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies Hum. Reprod., March 1, 2008; 23(3): 674 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. van Beek, M. M. van den Heuvel-Eibrink, J. S. E. Laven, F. H. de Jong, A. P. N. Themmen, F. G. Hakvoort-Cammel, C. van den Bos, H. van den Berg, R. Pieters, and S. M. P. F. de Muinck Keizer-Schrama Anti-Mullerian Hormone Is a Sensitive Serum Marker for Gonadal Function in Women Treated for Hodgkin's Lymphoma during Childhood J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3869 - 3874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fanchin, D. H. Mendez Lozano, N. Frydman, A. Gougeon, N. di Clemente, R. Frydman, and J. Taieb Anti-Mullerian Hormone Concentrations in the Follicular Fluid of the Preovulatory Follicle Are Predictive of the Implantation Potential of the Ensuing Embryo Obtained by in Vitro Fertilization J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1796 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Anderson and D. A. Cameron Assessment of the Effect of Chemotherapy on Ovarian Function in Women With Breast Cancer J. Clin. Oncol., April 20, 2007; 25(12): 1630 - 1631. [Full Text] [PDF]
|
|
|
|
|
|
R.A. Anderson, A.P.N. Themmen, A.A. -Qahtani, N.P. Groome, and D.A. Cameron The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer Hum. Reprod., October 1, 2006; 21(10): 2583 - 2592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Oktay, O. Oktem, A. Reh, and L. Vahdat Measuring the Impact of Chemotherapy on Fertility in Women With Breast Cancer J. Clin. Oncol., August 20, 2006; 24(24): 4044 - 4046. [Full Text] [PDF]
|
|
|
|
|
|
J. A Visser, F. H de Jong, J. S E Laven, and A. P N Themmen Anti-Mullerian hormone: a new marker for ovarian function Reproduction, January 1, 2006; 131(1): 1 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Skinner Regulation of primordial follicle assembly and development Hum. Reprod. Update, September 1, 2005; 11(5): 461 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Partridge and E. P. Winer Fertility After Breast Cancer: Questions Abound J. Clin. Oncol., July 1, 2005; 23(19): 4259 - 4261. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oehninger Strategies for Fertility Preservation in Female and Male Cancer Survivors Reproductive Sciences, May 1, 2005; 12(4): 222 - 231. [Abstract] [PDF]
|
|
|
|
|
|
W.H.B. Wallace and T.W. Kelsey Reply: ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography Hum. Reprod., April 1, 2005; 20(4): 1115 - 1116. [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. N. Themmen Anti-Mullerian Hormone: Its Role in Follicular Growth Initiation and Survival and as an Ovarian Reserve Marker J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 18 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. O. D. Critchley and W. H. B. Wallace Impact of Cancer Treatment on Uterine Function J Natl Cancer Inst Monographs, March 1, 2005; 2005(34): 64 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lutchman Singh, M. Davies, and R. Chatterjee Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.E. Bath, G. Tydeman, H.O.D. Critchley, R.A. Anderson, D.T. Baird, and W.H.B. Wallace Spontaneous conception in a young woman who had ovarian cortical tissue cryopreserved before chemotherapy and radiotherapy for a Ewing's sarcoma of the pelvis: Case report Hum. Reprod., November 1, 2004; 19(11): 2569 - 2572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Partridge, S. Gelber, J. Peppercorn, E. Sampson, K. Knudsen, M. Laufer, R. Rosenberg, M. Przypyszny, A. Rein, and E. P. Winer Web-Based Survey of Fertility Issues in Young Women With Breast Cancer J. Clin. Oncol., October 15, 2004; 22(20): 4174 - 4183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. Wallace and T. W. Kelsey Ovarian reserve and reproductive age may be determined from measurement of ovarian volume by transvaginal sonography Hum. Reprod., July 1, 2004; 19(7): 1612 - 1617. [Abstract] [Full Text] [PDF]
|
|